Phacilitate Leaders` Forum West 2012
March 12 - 14, 2012(Ended)
Westin San Francisco Market Street
San Francisco, CA, United States
San Francisco, CA, United States

The Phacilitate Leaders` Forum is a conference dedicated to therapeutic areas where there is significant unmet medical need, and where R&D challenges remain acute including prioritization, target selection, regulation, R&D, post-marketing surveillance and market access.
The Phacilitate Leaders` Forum consists of 3 co-located conferences including Metabolic Leaders’ Forum, Rare Disease Leaders’ Forum and Autoimmune & Inflammation Leaders’ Forum.
The Phacilitate Leaders` Forum brings together senior levels of R&D management from across big pharma and biotech companies.
The exhibitors at the event include:
- Suppliers of technologies and services relating to drug development, such as immune monitoring, imaging, gene expression measurements, biomarkers, pharmacogenomics and molecular diagnostics
- Cros and consultants providing development and regulatory services and advice
- Companies seeking partners for novel delivery systems or diagnostics
- Suppliers of software and it services related to data management, regulatory submission or project or portfolio management
- Consultants advising pharma and biotech companies on their r&d strategy, their portfolio and partnering strategy, or on product launches
Address
50 Third Street,
San Francisco,
California,
United States
San Francisco,
California,
United States
Prices *
1595-2595 US Dollar
Exhibition
Included
Organization
Categories
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Technology conferences — a useful tool
- A Study of clinical profile and treatment outcome of DOTS regime in 250 pulmonary and extra pulmonary patients in Hamidia hospital ,Bhopal in the year 2011
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Cancer Basic Research
- Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters.
- Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters





